104 related articles for article (PubMed ID: 31176697)
1. TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.
Qiu Y; Liu P; Ma X; Ma X; Zhu L; Lin Y; You Y; Yu W; Ma D; Sun C; Qin Z; Zhao Y; Shi J; Han L
Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1412-1420. PubMed ID: 31176697
[TBL] [Abstract][Full Text] [Related]
2. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation.
Ma X; Ma X; Qiu Y; Zhu L; Lin Y; You Y; Ma D; Qin Z; Sun C; Zhao Y; Sun Y; Han L
Cell Death Dis; 2018 May; 9(6):608. PubMed ID: 29789583
[TBL] [Abstract][Full Text] [Related]
3. TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization.
Lin Y; Lv X; Sun C; Sun Y; Yang M; Ma D; Jing W; Zhao Y; Cheng Y; Xuan H; Han L
EMBO Rep; 2022 Nov; 23(11):e54569. PubMed ID: 36178239
[TBL] [Abstract][Full Text] [Related]
4. TRIM50 Inhibits Gastric Cancer Progression by Regulating the Ubiquitination and Nuclear Translocation of JUP.
Hu J; Huang R; Liang C; Wang Y; Wang M; Chen Y; Wu C; Zhang J; Liu Z; Zhao Q; Liu Z; Wang F; Yuan S
Mol Cancer Res; 2023 Oct; 21(10):1107-1119. PubMed ID: 37409971
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein.
Zhu L; Qin C; Li T; Ma X; Qiu Y; Lin Y; Ma D; Qin Z; Sun C; Shen X; Zhao Y; Han L
Cell Death Differ; 2020 Jun; 27(6):1819-1831. PubMed ID: 31802035
[TBL] [Abstract][Full Text] [Related]
6. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
7. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
8. TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition
Li R; Zhu L; Peng Y; Zhang X; Dai C; Liu D
Front Oncol; 2021; 11():695740. PubMed ID: 34568024
[TBL] [Abstract][Full Text] [Related]
9. TRIM50 regulates Beclin 1 proautophagic activity.
Fusco C; Mandriani B; Di Rienzo M; Micale L; Malerba N; Cocciadiferro D; Sjøttem E; Augello B; Squeo GM; Pellico MT; Jain A; Johansen T; Fimia GM; Merla G
Biochim Biophys Acta Mol Cell Res; 2018 Jun; 1865(6):908-919. PubMed ID: 29604308
[TBL] [Abstract][Full Text] [Related]
10. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
11. Positive regulatory role of c-Src-mediated TRIM25 tyrosine phosphorylation on RIG-I ubiquitination and RIG-I-mediated antiviral signaling pathway.
Lee NR; Choi JY; Yoon IH; Lee JK; Inn KS
Cell Immunol; 2018 Oct; 332():94-100. PubMed ID: 30100205
[TBL] [Abstract][Full Text] [Related]
12. HDAC6 mediates the acetylation of TRIM50.
Fusco C; Micale L; Augello B; Mandriani B; Pellico MT; De Nittis P; Calcagnì A; Monti M; Cozzolino F; Pucci P; Merla G
Cell Signal; 2014 Feb; 26(2):363-9. PubMed ID: 24308962
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
14. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
Zheng Y; Zhang H; Sun H
Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
[TBL] [Abstract][Full Text] [Related]
16. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
17. Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.
Xiao J; Xu M; Hou T; Huang Y; Yang C; Li J
Mol Med Rep; 2015 Sep; 12(3):3249-3256. PubMed ID: 25975261
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
19. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
Yoo L; Yoon AR; Yun CO; Chung KC
Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
[TBL] [Abstract][Full Text] [Related]
20. Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase.
Yan Q; Wang F; Miao Y; Wu X; Bai M; Xi X; Feng Y
Tumour Biol; 2016 Sep; 37(9):12263-12271. PubMed ID: 27251670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
